Insider Transactions in Q3 2022 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,174
-1.99%
|
$24,654
$21.74 P/Share
|
|
Sep 21
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,174
+1.94%
|
$12,914
$11.0 P/Share
|
|
Sep 20
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
15,666
-7.36%
|
$313,320
$20.66 P/Share
|
|
Sep 20
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,666
+6.31%
|
$93,996
$6.76 P/Share
|
|
Sep 13
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
22,363
-5.81%
|
$469,623
$21.13 P/Share
|
|
Sep 13
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,363
+5.49%
|
$44,726
$2.9 P/Share
|
|
Sep 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
16,136
-4.2%
|
$322,720
$20.8 P/Share
|
|
Sep 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,136
+3.98%
|
$32,272
$2.9 P/Share
|
|
Sep 09
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
12,886
-6.64%
|
$257,720
$20.16 P/Share
|
|
Sep 09
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,886
+6.23%
|
$25,772
$2.9 P/Share
|
|
Sep 08
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,106
-7.7%
|
$302,120
$20.52 P/Share
|
|
Sep 08
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,106
+7.15%
|
$30,212
$2.9 P/Share
|
|
Sep 07
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
6,785
-3.61%
|
$135,700
$20.03 P/Share
|
|
Sep 07
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,785
+3.48%
|
$13,570
$2.9 P/Share
|
|
Sep 07
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
988
-3.32%
|
$17,784
$18.63 P/Share
|
|
Sep 02
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
17,096
-4.5%
|
$341,920
$20.88 P/Share
|
|
Sep 02
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,096
+4.31%
|
$34,192
$2.9 P/Share
|
|
Sep 01
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
17,100
-8.63%
|
$359,100
$21.22 P/Share
|
|
Sep 01
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,100
+7.94%
|
$34,200
$2.9 P/Share
|
|
Aug 22
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,630
-2.66%
|
$30,970
$19.04 P/Share
|
|
Aug 22
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+2.59%
|
$17,930
$11.0 P/Share
|
|
Aug 19
2022
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+48.16%
|
-
|
|
Aug 19
2022
|
Celia Lin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Aug 19
2022
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
33,750
+48.9%
|
-
|
|
Aug 19
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+19.45%
|
-
|
|
Aug 19
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,909
-3.66%
|
$131,271
$19.31 P/Share
|
|
Aug 19
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,909
+3.48%
|
$41,454
$6.76 P/Share
|
|
Aug 19
2022
|
Joanne Curley Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+29.56%
|
-
|
|
Aug 17
2022
|
Carlyle Group Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,925
-0.11%
|
$198,500
$20.46 P/Share
|
|
Aug 17
2022
|
Carlyle Group Inc. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,925
+0.33%
|
$109,175
$11.0 P/Share
|
|
Aug 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,528
-13.0%
|
$410,560
$20.16 P/Share
|
|
Aug 12
2022
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,528
+11.5%
|
$41,056
$2.9 P/Share
|
|
Aug 03
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
988
-5.41%
|
$15,808
$16.81 P/Share
|
|
Jul 19
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,444
-11.92%
|
$183,104
$16.28 P/Share
|
|
Jul 19
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,444
+9.63%
|
$45,776
$4.64 P/Share
|
|
Jul 14
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,104
-18.15%
|
$136,560
$15.15 P/Share
|
|
Jul 14
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+18.84%
|
$12,708
$2.9 P/Share
|
|
Jul 07
2022
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,666
-12.33%
|
$144,990
$15.05 P/Share
|
|
Jul 07
2022
|
Joanne Curley Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,001
+11.41%
|
$28,004
$4.64 P/Share
|